Clinical Trial Update: Effect of Dupilumab on Nasal Epithelial Barrier Function in Patients With CRSwNP

View source ↗

Summary

An ongoing clinical trial is evaluating the effect of dupilumab on nasal epithelial barrier function in patients with chronic rhinosinusitis with or without nas…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rhinosinusitis Without Nasal Polyps
• Rhinosinusitis with Nasal Polyps

Drugs mentioned

• Dupilumab (dupilumab)

Snippet

Sponsor: Medical University of Vienna | Conditions: Chronic Rhinosinusitis With Nasal Polyps, Chronic Rhinosinusitis Without Nasal Polyps | Status: RECRUITING